US Equity
ESPR
— ESPERION THERAPEUTICS, INC.Esperion Therapeutics, Inc. is a pharmaceutical company that develops and commercializes oral therapies for the treatment of elevated LDL cholesterol.
💰 Market cap: $819.47M📍 3891 Ranchero Drive, Suite 150, Suite 300, ANN ARBOR, MI, 48108 US🏷️ Pharmaceuticals💵 Previous close: $3.19🔢 9,718 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-10 | $3.18 |
| 2026-07-09 | $3.19 |
| 2026-07-08 | $3.19 |
| 2026-07-07 | $3.16 |
| 2026-07-06 | $3.15 |
| 2026-07-02 | $3.16 |
| 2026-07-01 | $3.16 |
| 2026-06-30 | $3.16 |
| 2026-06-29 | $3.15 |
| 2026-06-26 | $3.17 |
| 2026-06-25 | $3.15 |
| 2026-06-24 | $3.15 |
| 2026-06-23 | $3.16 |
| 2026-06-22 | $3.16 |
| 2026-06-18 | $3.15 |
| 2026-06-17 | $3.17 |
| 2026-06-16 | $3.16 |
| 2026-06-15 | $3.15 |
| 2026-06-12 | $3.15 |
| 2026-06-11 | $3.15 |
| 2026-06-10 | $3.14 |
| 2026-06-09 | $3.14 |
| 2026-06-08 | $3.15 |
| 2026-06-05 | $3.13 |
| 2026-06-04 | $3.13 |
| 2026-06-03 | $3.14 |
| 2026-06-02 | $3.14 |
| 2026-06-01 | $3.13 |
| 2026-05-29 | $3.13 |
| 2026-05-28 | $3.13 |
| 2026-05-27 | $3.13 |
| 2026-05-26 | $3.12 |
| 2026-05-22 | $3.13 |
| 2026-05-21 | $3.13 |
| 2026-05-20 | $3.13 |
| 2026-05-19 | $3.13 |
| 2026-05-18 | $3.13 |
| 2026-05-15 | $3.12 |
| 2026-05-14 | $3.12 |
| 2026-05-13 | $3.12 |
| 2026-05-12 | $3.13 |
| 2026-05-11 | $3.13 |
| 2026-05-08 | $3.14 |
| 2026-05-07 | $3.14 |
| 2026-05-06 | $3.15 |
| 2026-05-05 | $3.12 |
| 2026-05-04 | $3.12 |
| 2026-05-01 | $3.11 |
| 2026-04-30 | $2.00 |
| 2026-04-29 | $1.91 |
| 2026-04-28 | $1.91 |